NASDAQ · TNON
Healthcare · Medical - Devices
$1.89
Down-$0.02 (-0.79%)
Updated Nov 4, 2026, 4:36 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · TNON
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
TNON closed at $1.89 after 21 trading sessions, down 49.13% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $1.93 | $2.04 | $1.84 | $1.89 | 78.12K |
| Nov 2, 2026 | $2.09 | $2.1799 | $1.93 | $1.93 | 61.38K |
| Oct 30, 2026 | $2.27 | $2.27 | $2.05 | $2.05 | 172.51K |
| Oct 29, 2026 | $2.27 | $2.34 | $2.17 | $2.29 | 126.19K |
| Oct 28, 2026 | $2.28 | $2.30 | $2.1601 | $2.26 | 445.54K |
| Oct 27, 2026 | $2.16 | $2.27 | $2.14 | $2.14 | 163.06K |
| Oct 26, 2026 | $2.20 | $2.20 | $2.10 | $2.155 | 62.09K |
| Oct 23, 2026 | $2.27 | $2.2741 | $2.17 | $2.20 | 80.12K |
| Oct 22, 2026 | $2.45 | $2.479 | $2.225 | $2.24 | 112.24K |
| Oct 21, 2026 | $2.47 | $2.59 | $2.42 | $2.51 | 86.73K |
| Oct 20, 2026 | $2.46 | $2.54 | $2.42 | $2.51 | 83.98K |
| Oct 19, 2026 | $2.58 | $2.615 | $2.43 | $2.45 | 158.65K |
| Oct 16, 2026 | $2.95 | $3.06 | $2.67 | $2.70 | 217.89K |
| Oct 15, 2026 | $2.83 | $2.93 | $2.78 | $2.91 | 150.04K |
| Oct 14, 2026 | $2.82 | $2.94 | $2.80 | $2.82 | 158.57K |
| Oct 13, 2026 | $2.98 | $3.10 | $2.85 | $2.89 | 228.54K |
| Oct 12, 2026 | $3.34 | $3.36 | $2.9501 | $2.98 | 264.34K |
| Oct 9, 2026 | $3.41 | $3.52 | $3.37 | $3.41 | 133.89K |
| Oct 8, 2026 | $3.46 | $3.5779 | $3.42 | $3.44 | 115.54K |
| Oct 7, 2026 | $3.58 | $3.64 | $3.38 | $3.50 | 356.19K |
| Oct 6, 2026 | $3.80 | $3.82 | $3.62 | $3.715 | 428.81K |
The latest Smart Investors Daily articles mentioning TNON.
Company
Market Activity
Research & News
TNON research
Company profile and research snapshot.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 9, 2025 | Alliance Global Partners | Buy | — |
| Nov 15, 2024 | Maxim Group | Buy | — |
| Aug 14, 2024 | Benchmark | Speculative Buy | — |
| Apr 15, 2024 | Benchmark | Speculative Buy | — |
| Mar 10, 2023 | Benchmark | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 29, 2026
LOS GATOS, CA / ACCESS Newswire / October 29, 2026 / , Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced plans to release financial results for the third quarter ended September 30, 2026 after market close on Thursday, November 12, 2026.
Yahoo · Oct 28, 2026
~ New decortication system is the latest advancement in Tenon's next-generation SI joint fusion platform with additional innovative product launches expected in the coming quarters ~~ Quickstep Decorticator designed to streamline joint decortication and simplify the SImmetry+ surgical workflow ~~ Full market release of Quickstep targeted for the first quarter of 2027. Company believes Quickstep will further support long-term adoption of the SImmetry+ System ~LOS GATOS, CA / ACCESS Newswire / Oct
Benzinga · Oct 28, 2026
Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced the completion of the initial alpha cases with its new
Benzinga · Oct 16, 2026
https://www.sec.gov/Archives/edgar/data/1560293/000121390026110252/ea0308890-424b5_tenon.htm
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning TNON.
